Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Will Underperforming Japan Business Weigh On Aflac (AFL)?

Published 03/08/2020, 10:05 PM
Updated 07/09/2023, 06:31 AM

Investors are currently concerned about Aflac Inc. (NYSE:AFL) business loss in Japan due to its sales practices within a key distribution channel in the region.

Nearly 80% of Aflac’s revenues come from its Japan business. This business has been underperforming over the years due to the ultra low interest rates in the region. In an effort to deal with the low interest rate, the company shifted its product offering to third sector products that are less interest rate sensitive and have strong and stable margins.

The effect of low interest rates is much pronounced on life insurance companies given their rate-sensitive products and investments. Companies like American International Group Inc. (NYSE:AIG) , MetLife, Inc. (NYSE:MET) and Lincoln National Corp. (NYSE:LNC) are some of the major life insurers in the industry.

Last year, this business hit another roadblock as Japan Post Holdings (consisting of JPI, JPC and Japan Post Group), one of the major distributors of cancer insurance, was accused of improper sales practices. JPC and JPI are important distribution and alliance partners of the company, which in 2019 collectively accounted for approximately 25% of Aflac Japan’s third sector sales. The investigation into the matter is continuing and is likely to be completed by the end of June 2020.

There is no surety of re-initiation of sales of JPI insurance products. Notwithstanding the JPI investigation and the three-month suspension orders promulgated by the FSA and the Japan Ministry of Internal Affairs and Communications, the sale of Aflac Japan cancer policies has continued through JPC and JPI.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

However, while the sale of Aflac Japan cancer insurance products is not within the scope of the suspension orders, beginning in August 2019, the company experienced a material decrease of sales in the Japan Post Group channel. This decline has continued into 2020. The company believes that sales of Aflac Japan cancer insurance through JPC and JPI are unlikely to return to 2018 levels in the near term. In 2019, new annualized premium sales declined 15.9% year over year.

For 2020, the company expects a decline of 0.7% in third sector and first sector protection earned premium for the year. Also, net investment income is expected to decrease modestly as compared to 2019, due to the low interest rate environment in Japan and de-risking of the portfolio, partially offset by lower hedge cost as a result of a reduction in the hedge ratio in the fourth quarter of 2019.

Thus, pressure on revenues from Japan is likely to hurt earnings till the investigation resolves.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>




3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Lincoln National Corporation (LNC): Free Stock Analysis Report

Aflac Incorporated (AFL): Free Stock Analysis Report

American International Group, Inc. (AIG): Free Stock Analysis Report

MetLife, Inc. (MET): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.